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Microwave ablation (MWA) is a type of minimally invasive cancer therapy that uses heat to induce 
necrosis in solid tumours. Inter- and post-ablational size changes can influence the accuracy of control 
imaging, posing a risk of incomplete ablation. The present study aims to explore post-ablation 3D size 
dynamics in vivo using computed tomography (ct). ten MWA datasets obtained in nine healthy pigs 
were used. Lesions were subdivided along the z-axis with an additional planar subdivision into eight 
subsections. The volume of the subsections was analysed over different time points, subsequently 
colour-coded and three-dimensionally visualized. A locally weighted polynomial regression model 
(LoeSS) was applied to describe overall size changes, and Student’s t-tests were used to assess 
statistical significance of size changes. The 3D analysis showed heterogeneous volume changes with 
multiple small changes at the lesion margins over all time points. the changes were pronounced at the 
upper and lower lesion edges and characterized by initially eccentric, opposite swelling, followed by 
shrinkage. In the middle parts of the lesion, we observed less dimensional variations over the different 
time points. LOESS revealed a hyperbolic pattern for the volumetric changes with an initially significant 
volume increase of 11.6% (111.6% of the original volume) over the first 32 minutes, followed by a 
continuous decrease to 96% of the original volume (p < 0.05).
Microwave ablation (MWA) is a thermoablative procedure for the minimally invasive therapy of solid tumours, 
primarily in the lungs, kidneys and liver. It uses electromagnetic waves to induce local coagulation necrosis 
through heat1–3. During the ablation procedure, high local temperatures of up to 120 °C can be achieved in the 
target tissue, not only causing protein denaturation but also for example evaporation of the water contained in the 
tissue and resulting in changes of dielectric and thermal properties as well as structural tissue changes4–6. Overall, 
these structural changes can lead to dynamic alterations in lesion morphology and lesion size in the post-ablation 
period. Tissue shrinkage, primarily caused by dehydration, but also by tissue evaporation and carbonization, is an 
important change in the ablation area and ought to be considered in post-interventional imaging as it can cause a 
decrease in lesion volume of up to 30% and could therefore be of clinical relevance7–9.
Contrast-enhanced computed tomography (CECT) is often performed after MWA to determine the size and 
safety margin of the ablation area in order to ensure complete tumour ablation10–13. CECT has been shown to 
allow identification of the central necrotic area of the ablated tissue, which displays little to no contrast medium 
uptake and thus appears hypodense compared to normal liver tissue (NLT)14. Recent studies using CECT ex vivo 
or in vivo demonstrated the shrinkage of ablation zones in the first hours after MWA, but so far, no precise anal-
ysis of the dynamic size behaviour has been carried out7,8,15. However, precise knowledge of size could improve 
post-interventional assessment of ablation zones, as it also allows for evaluation of post-ablational shrinkage 
when evaluating sufficiency of the safety margin. Therefore, the present study aims to investigate the following 
aspects: firstly, to examine 3D volume changes of the ablation zones within the first hours after MWA; secondly, 
to analyse the patterns in size changes of different lesion areas within the ablation zone, and thirdly, to model the 
general lesion size behaviour over time.
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Results
MWA was performed in twelve anaesthetized pigs (154 ± 24 days, 79 kg ± 12 kg). Measurements at four different 
time points were performed for ten ablations in nine pigs; in three pigs, fewer than four measurements could be 
carried because the animals became unstable and the experiment had to be stopped. The median MWA duration 
was 15:00 min with a mean maximum temperature of 82 °C ± 44 °C. The average time between measurements 
was 13 (Interquartile Range (IQR): 20) min, more specifically, 20 ± 17 min between the first and second measure-
ments, 14 (IQR: 5) min between the second and third measurements and 19 ± 9 min between the third and fourth 
measurement. Overall, 65 to 112 min passed between initial imaging immediately after the ablation and the final 
(fourth) imaging of the lesion
Lesion morphology. The lesions were predominantly ellipsoidal, with one lesion being predominantly 
spherical. They measured 52 ± 14 mm along the z-axis (first time point). Distally, around the tip of the antenna, 
the ablated lesions tended to have a larger diameter than at the proximal end (see Fig. 1 and Table 1). The inner 
region of the lesions appeared hypodense compared to the surrounding healthy liver tissue and was surrounded 
by a peripheral zone of increased contrast enhancement of highly variable intensity among lesions. A hypodense 
defect or a small hyperdense haemorrhage was observed centrally in the branch canal.
3D assessment of size dynamics. The mean volume of lesions in the first measurement (immediately 
after ablation) was 15 ± 10 cm³, followed by an increase in volume in the second to third measurement and a 
subsequent decrease in the following measurements. 3D analysis revealed random size changes in the marginal 
lesion areas with small increases and decreases in volume of the lesion’s subsections, which, however, seemed not 
to contribute substantially to the overall initial increase and subsequent decrease in lesion volume. By contrast, we 
observed more pronounced dynamics of volumetric changes at the upper and lower poles of the lesion (defined 
as the upper and lower 25% of the lesions in the z-axis). Here, the lesion inflated and subsequently deflated over 
time following ablation. A noteworthy example of this process is given in Fig. 2. The parts of the lesion located 
centrally alongside the z-axis, however, seemed to have a more constant size dynamics with slower but constant 
shrinkage. The mean volumetric increase of the lesion poles after 32 min was 14% for the upper pole and 12% for 
the lower pole, while the central parts showed a smaller percentage increase of 5%. After 90 min, the upper pole 
Figure 1. Example of asymmetric lesion configuration. Shows a lesion with the largest diameter at the lower 
pole and a smaller diameter at the upper pole instead of an overall spherical configuration. Similar shapes were 
found for most other lesions.
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volume decreased to 79% and the lower pole volume to 94% of the original size, while the central part showed a 
persistent minor swelling of 3%. Still, despite the asymmetric volumetric changes, the configuration of the lesion 
at the fourth measurement largely corresponded to that of the initial time point, so that the increase and decrease 
ultimately remained symmetrical.
Modelling the size behaviour of lesions after MWA. After displaying the percentage change in volume 
compared to the elapsed time in a scatterplot, a locally weighted polynomial regression (LOESS) model (Fig. 3) 
was fitted on the data using a span of α = 1 for smoothing. The model showed an initial maximum increase in 
lesion volume to 111.6% (95% Confidence Interval (CI)116.6–106.5%) after 32 min with subsequent decrease. 
The lesions consecutively decreased in volume, with a small residual swelling after 60 min to 102.9% (95% CI 
97.7–108%) of the initial lesion volume. The approximate initial volume was reached again after 63 min (95% 
CI 31–83 min), followed by a further decrease to 97.5% (95% CI 92.1–102.9%) after 75 min and to 96% (95% CI 
89.3–102.7%) after 90 min. Altogether, the model shows a moderate fit to the data with a mean squared error 
(MSE) of 101.2 and a correlation of r = 0.58 (95% CI: 0.33–0.76, p < 0.001) between fitted values and original 
values.
Discussion
The present study suggests that volume changes after MWA are more pronounced at the lower and upper poles of 
the lesion, although small random changes may occur throughout the entire lesion. Overall, lesions in our experi-
ments showed an initial swelling up to 111.6% at 30 min after ablation with 32 minutes and a subsequent decrease 
to 96% of the original size after 90 min.
The initial swelling of ablated lesions, as observed in the first half hour after MWA, is a surprising observa-
tion, which stands in contrast to the findings of some previous ex vivo studies7,8,15,16. An ex vivo study in bovine 
livers performed by Amabile et al. showed a linear correlation of shrinkage and time after ablation, while Brace 
et al. also demonstrated a linear decrease in the lesion size7,8. Conversely, in an ex vivo experiment, Farina et al. 
observed an increase in lesion size in the first minutes before subsequent shrinkage17. While they attributed the 
initial expansion to evaporation of tissue fluid during ablation and formation of gas bubbles17, it seems unlikely 
that this process would lead to a continuous lesion expansion for half an hour after ablation, as observed in the 
present study. Therefore, we assume that the protracted tissue swelling more likely results from osmotically active 
electrolytes, which are released from former intercellular spaces of the damaged cells during ablation and reactive 
oedema formation. However, volumetric dynamics differed between the individual lesions. Compared to other 
lesions, one lesion showed delayed dynamics with persistent swelling in the fourth measurement (lesion number 
two). In this case, our 3D analysis showed a largely homogeneous change over the entire lesion. The lesion was 
very close to the diaphragm, but no other possible influencing factors, such as large adjacent vessels, could be 
Lesion No. Location Structural pattern Volumetric behaviour
1
Left hepatic lobe
Close to the diaphragm
Vessel at the lower pole
Small lesion
predominantly oval Steady decrease in volume
2
Left hepatic lobe












Hyperbolic behaviour, overall decrease at 4th 
time point
4 Centrally in the right hepatic lobeSmall adjacent vessel at the lower pole
Medium sized lesion
Oval with a central bulge





Central large vessels in frontal view and at 
the back of the lower pole
Small sized lesion
Predominantly oval
Central notch in frontal view 
(see Fig. 4)
Hyperbolic behaviour, overall decrease at 4th 
time point




Hyperbolic behaviour, Same volume at 1st and 
4th time point
7 Centrally in the right hepatic lobeAdjacent vessel at the lower pole
Large lesion
Predominantly round with bulge 
at the lower pole
Hyperbolic behaviour
Prolonged swelling at 3rd time point
8
Right hepatic lobe





Strong decrease in volume at 3rd time point
9 Centrally in the right hepatic lobeNo adjacent vessel
Medium sized lesion
Predominantly oval (see Fig. 1).









Hyperbolic behaviour, moderate volumetric 
increase at 2nd, but strong decrease at 4th time 
point
Table 1. Gives and overview of lesion locations, structural patterns and volumetric behaviour. It is noteworthy 
that lesions in close proximity to larger vessels showed more notches or bulges in their structures than lesions 
without adjacent vessels. Also, lesions located close to the diaphragm tended to display more marked volumetric 
changes.
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identified to explain the prolonged swelling. The most pronounced volumetric dynamics could be observed in 
lesion number five. On closer inspection in the 3D analysis, we identified an area through which a large vessel 
passed. This area showed a prominent initial swelling which only slowly receded and seemed to predominantly 
account for the lesion’s overalls volume changes (see Fig. 4 for 3D reconstructions).
Figure 2. Example of a 3D reconstruction. Shows 3D reconstructions of lesion number ten in the frontal view 
over four consecutive time points (T1–4). The reconstruction of the first measurement is on the left (T1), 
followed from left to right by the second, third and fourth measurement (T2–4, respectively). The colour scale 
always refers to the percentage change in size compared to the previous measurement, with blue indicating 
shrinkage and yellow, orange and red indicating a slight, moderate and marked increase in size in the respective 
area. The colours indicate the local size changes and not the overall size change. Some small areas show variable 
size changes which did not seem to follow the overall pattern with selectively emphasized shrinkage of up to 
80%, or a renewed increase of the volume, as for example indicated by the red colouration in the lower pole at 
time point four (T4). For the lesion shown here, these size dynamics led to a total volume decrease of 24% at 
92 min compared with the original lesion volume.
Figure 3. Overall size behaviour of all lesions. Shows the percentage size change starting from the first 
measurement (100%) over the time elapsed since the ablation procedure. The black curve was generated using a 
local polynomial regression model (LOESS) with the corresponding 95% confidence interval as grey area. This 
model shows an overall hyperbolic size behaviour of the lesions. One lesion shows more dramatic volumetric 
behaviour with an increase of nearly 40% at the first time point. This might in part be attributable to the overall 
small size of the lesion and its close proximity to a larger vessel.
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It has been described that, macroscopically and histologically, MWA lesions can be divided into two zones, an 
inner zone, also referred to as white zone, and an outer transitional zone, also referred to as red zone13,18. While the 
inner white zone is completely necrotic, the transitional zone contains vital tissue with a partially preserved tissue 
structure. As the vascular structure may partially be preserved in the outer zone, this could be a plausible explana-
tion for an increased influx of water from the surrounding tissue and the observed initial swelling. With increasing 
organization of the ablated area in the further course, the osmotically active molecules might then be degraded, 
resulting in lesion shrinkage, as conversion processes begin to dominate. Considering that all the above-referenced 
studies had ex vivo designs, this effect might not have been observed previously because dead tissues show less 
water and electrolyte exchange/reactive rebuilding compared to living tissues. However, further studies, especially 
with in vivo designs, are needed to support this theory. Studies with a 3D histopathologic reference standard, pref-
erably with a nicotinamide adenine dinucleotide (NADH) vital stain, are considered particularly promising. The 
fact that the volume changes are more pronounced at the upper and lower poles may be due to the larger borders 
of the poles with healthy liver tissue compared to the central parts of the lesions, leading to a larger percentage of 
the transitional zone in this area (also see the schematic drawing in Fig. 5). The observed small, seemingly random 
changes in the peripheral area of the lesions probably result from a combination of inaccuracies in image segmen-
tation, subtle motion artefacts and true small volumetric changes in the transitional zone.
A better understanding of the lesion size behaviour may help to improve MWA, since insufficient ablation 
might be more reliably identified with adequate consideration of size dynamics. In particular, knowledge of the 
initial swelling of the lesion within the first half hour, during which immediate control images are usually taken, 
would allow the interventionalist to directly perform additional ablation procedures whenever the initial abla-
tion zone was too small. The initial swelling might thus mask incomplete ablation with the possible presence of 
residual tumour in the peripheral zone. Under the assumption that the volumetric changes primarily involve the 
transitional zone and considering the initial increase in volume, the chosen safety margin of ablations should be 
evaluated depending on the interval between the ablation and image acquisition. This implies that an observed 
safety margin of 5 mm, as currently recommended19, is adequate for image acquisition immediately after ablation, 
Figure 4. Example of a 3D reconstruction (lesion number five). Shows 3D reconstructions of lesion number 
five in the frontal view (A1–4) and in the rear view (B1–4). The reconstruction of the first measurement is on 
the left (A1/B1), followed from left to right by the second, third and fourth measurement (A2/B2, A3/B3, A4/
B4, respectively). A strong but delayed increase in lesion volume can be detected in the third measurement (A3) 
adjacent to a vessel, which is indicated by the notch in the middle of the lesion in the frontal view. This increase 
in volume even continues in the fourth measurement (A4). Smaller size changes, with no clear pattern, can also 
be observed across time points. For example, a regional decrease in volume is seen at the back of the lesion in 
measurement 3 (B3), followed by a strong increase in the next measurement (B4) despite an overall decrease in 
lesion size.
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but might not be the optimal choice if imaging is performed later. In this case, as an increase in lesion volume 
might lead to an increase of the transitional zone to more than 5 mm, making the previously chosen safety margin 
insufficient. Rather, the extent of the safety margin should be chosen in dependence on the time passed since the 
ablation. For example, half an hour after ablation, the maximally measured increase in lesion size was 40%, cor-
responding to an individually adapted consequently the safety margin of should be adapted accordingly, which 
would correspond to 7 mm. In subsequent follow up (>24 h) imaging studies, lesion shrinkage, must be consid-
ered in evaluating whether complete ablation has been accomplished. However, our analysis suggests that the 
shrinkage is irregular, and, although the lesion poles appear to change more markedly in volume, it is not possible 
to deduce retrospectively, where the most dominant size changes have occurred. Therefore, a further reduction of 
the safety margin may be dangerous for the patient. Tissue shrinkage should also be considered for intermediate 
post-ablational imaging, when certain events cause a time delay. If the effect of shrinkage is not known to the 
performing interventionalist, this may lead to the false conclusion, that the ablation is inadequate. If this leads to 
re-ablation, this would cause unnecessary damage to liver-tissue and vessels. Another aspect is, that our analysis 
only covered a timeframe of up to two hours after the ablation. Therefore, the strong decrease in the second hour, 
as seen in Fig. 3, will likely weaken over time, making extrapolation of original lesion size from later post-ablation 
images challenging.
This study has some limitations. Due to the open cavity approach, hypothermia became more threatening 
with duration of the experiment. Therefore, the examination was usually stopped after the last ablation before the 
vital parameters became unstable. This might have resulted in a certain heterogeneity of the measurements and 
have reduced statistical significance due to the low numbers of measurements with four or more time points. We 
used domestic pigs and the properties of a healthy pig’s liver in terms of heat transmission could be different from 
those of a human liver containing cancerous tissue. Therefore, our results may not be fully transferable to humans 
with liver tumours. We used a low-power MW generator, which could have affected not only the lesion size but 
also the size dynamics and our findings are therefore probably not fully transferable to other devices. Compared 
to previous ex vivo studies, we also had longer ablation times, probably due to a lower power output from the 
MW generator as well as heat dissipation due to tissue perfusion and a heat sink effect near larger vessels. It is also 
possible that inflammatory processes have affected lesion dynamics, if one animal underwent multiple ablations. 
Taken together, these may have altered the volumetric changes of the lesions. As the LOESS model did not correct 
for possible clustering of the data, it might not be fully generalizable.
Overall, the lesion volume seems to follow a hyperbolic course after ablation with an initial swelling (over a 
period of half an hour) and a subsequent decrease to 96% of the original volume after four hours. Size dynamics 
are mainly attributable to volumetric changes at the upper and lower poles, although small random changes may 
occur throughout the entire lesion. One possible conclusion could be that the changes in volume are mainly 
attributable to osmotic processes of the partly vital tissue in the outer transitional lesion zone. Therefore, evalua-
tion of the safety distance after ablation should be based on the time elapsed between ablation and imaging and, 
if necessary, the chosen margin ought to be adapted.
Figure 5. Schematic illustration of size changes. Shows a schematic representation of the size changes over four 
different measuring points, the top row along the electrode (A1–D1) and the bottom row in the cross section 
(A2–B2). Size changes mainly occur in the transitional zone, which provides a possible explanation for the 
asymmetric size behaviour.
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Methods
Animals, housing and care. MWA was carried out on domestic pigs in our facility. The animals were kept 
under controlled conditions in the stables of our facility and supplied with food and drinking water, in accordance 
with the local guidelines and rules for the implementation of the Animal Welfare Act. Prior to the interventions, 
the pigs were anaesthetized, and median laparotomy was performed. The study and all interventions were carried 
out in accordance with the guidelines and rules of the Federation of Laboratory Animal Science Associations 
(FELASA) and were approved by the National Office for Health and Social Affairs. This study was approved by 
the institutional review board of Charité - Universitätsmedizin Berlin.
Microwave ablation. The electrodes for the microwave ablation (AveCure, MedWaves Incorporated, San 
Diego, USA) were inserted into the pig liver under CT fluoroscopy after the liver had been surgically exposed 
through a laparotomy. Ablations with post-ablational imaging were performed in an open cavity approach, result-
ing in a total of ten ablations with measurements at four consecutive time points, which were evaluated in this 
paper. Every MWA was performed for a median duration of 15 minutes with a power of 40 W. A target energy of 
24 kJ was continuously delivered into the tissue during physiological blood flow and liver perfusion. After each 
ablation, a plastic tube was inserted into the centre of the lesion alongside the antenna to enable the reliable visu-
alization of the lesion centre and the former position of the MWA antenna in the CT images.
contrast enhanced computed tomography. Delayed CECT scans were obtained after each MWA using 
an 80-slice multi-detector CT scanner (Aquilion PRIME, Canon Medical Systems Cooperation, Otawara, Japan) 
with the following parameters: 120 kV, 400 mA, mean mAs 260, collimated slice thickness 80 × 0.5 mm, 0.5 s rota-
tion speed, pitch factor 0.814. The craniocaudal extension of the scanned area was 16 cm, covering the complete 
liver of the pig. For each scan, an iodinated contrast agent (100 ml) with a concentration of 400 mg I/ml (Imeron 
® 400, Bracco Imaging, Milan, Italy) was administered at an injection rate of 4 ml/s.
Data analysis. Images were exported as Digital Imaging and Communications in Medicine (DICOM) files in 
a 3D-image stack and imported into ITK-SNAP V 3.6.0 for semi-automatic segmentation of the lesion20. The first 
step was choosing a threshold density, which was held constant for every consecutive lesion. Next, the lesion was 
segmented using a region-growing algorithm. The hyperdense rim, which surrounded some ablations, was not 
included in the segmentation. Thereafter, 3D segmentations were imported into the “R” statistical environment 
(Version 3.4.0 - The R Foundation for Statistical Computing) as 3D arrays using the “oro.dicom” package21,22. 
Since the original images had slightly different size ratios, the arrays were first resized according to the pixel 
spacing stored in the DICOM header. For the analysis, the lesions were divided into 2D matrices along the z-axis 
and then further subdivided into eight subsections using the same segmentation mask for all lesions. Volumetric 
changes in these subdivisions were analysed qualitatively and quantitatively over the four time points and colour 
coded. The lesion volume was calculated from the pixel number and pixel spacing. Each colour-coded 2D matrix 
was exported into the uncompressed Tagged Image File Format (TIFF) and, subsequently, the generated image 
stacks were imported into ImageJ23,24. Surface meshes and 3D volume reconstructions were generated using the 
3D visualization application programming interface (API) for ImageJ25.
Statistical analysis. Statistical analysis was performed using the “R” statistical software environment 
Version 3.4.0 - The R Foundation for Statistical Computing) including the “ggplot2” package for graphical dis-
play21,26. Variables were expressed as mean ± standard deviation, if normally distributed, and as median (inter-
quartile range - IQR) if not. To estimate the shrinkage, the percentage lesion volume was calculated in comparison 
to the first measurement taken directly after the MWA and correlated to the elapsed time. A locally weighted pol-
ynomial regression model was used to describe overall volumetric changes. Student’s t-tests were applied to assess 
the statistical significance of size changes over time. A p-value < 0.05 was considered statistically significant.
Data availability
The datasets generated and/or analysed during the current study are available from the corresponding author 
upon reasonable request.
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